ALS-Linked SOD1 Mutant G85R Mediates Damage to Astrocytes and Promotes Rapidly Progressive Disease with SOD1-Containing Inclusions

Superoxide dismutase: Improved assays and an assay applicable to acrylamide gels

Beauchamp, C., & Fridovich, I. (1971) · Analytical Biochemistry · doi:10.1016/0003-2697(71)90370-8 · Cited by 12,892

Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis

Rosen, D. R., Siddique, T., Patterson, D., Figlewicz, D. A., Sapp, P., Hentati, A., Donaldson, D., Goto, J., O'Regan, J. P., Deng, H.-X., et al. (1993) · Nature · doi:10.1038/362059a0 · Cited by 7,062

Motor Neuron Degeneration in Mice that Express a Human Cu,Zn Superoxide Dismutase Mutation

Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., Caliendo, J., Hentati, A., Kwon, Y. W., Deng, H.-X., et al. (1994) · Science · doi:10.1126/science.8209258 · Cited by 4,143

GDNF: a Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic Neurons

Lin, L.-F. H., Doherty, D. H., Lile, J. D., Bektesh, S. L., & Collins, F. (1993) · Science · doi:10.1126/science.8493557 · Cited by 3,206

Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?

Halliwell, B. B. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92211-x · Cited by 2,926

Knockout of Glutamate Transporters Reveals a Major Role for Astroglial Transport in Excitotoxicity and Clearance of Glutamate

Rothstein, J. D., Dykes-Hoberg, M., Pardo, C. A., Bristol, L. A., Jin, L., Kuncl, R. W., Kanai, Y., Hediger, M. A., Wang, Y., Schielke, J. P., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80086-0 · Cited by 2,534

Cellular defenses against damage from reactive oxygen species

Yu, B. (1994) · Physiological Reviews · doi:10.1152/physrev.1994.74.1.139 · Cited by 2,382

Localization of neuronal and glial glutamate transporters

Rothstein, J. D., Martin, L. J., Levey, A. I., Dykes‐Hoberg, M., Jin, L., Wu, D. M., Nash, N. R., & Kuncl, R. W. (1994) · Neuron · doi:10.1016/0896-6273(94)90038-8 · Cited by 1,703

Amyotrophic Lateral Ssclerosis and Structural Defects in Cu,Zn Superoxide Dismutase

Deng, H., Hentati, A., Tainer, J. A., Iqbal, Z., Cayabyab, A., Hung, W.-Y., Getzoff, E. D., Hu, P., Herzfeldt, B., Roos, R. P., et al. (1993) · Science · doi:10.1126/science.8351519 · Cited by 1,479

Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis

Rothstein, J. D., Van Kammen, M., Levey, A. I., Martin, L. J., & Kuncl, R. W. (1995) · Annals of Neurology · doi:10.1002/ana.410380114 · Cited by 1,471

Does excitotoxic cell death of motor neurons in ALS arise from glutamate transporter and glutamate receptor abnormalities?

Rattray, M., & Bendotti, C. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.05.001 · Cited by 26

Glutamate leakage from a compartmentalized intracellular metabolic pool and activation of the lipoxygenase pathway mediate oxidative astrocyte death by reversed glutamate transport

Ré, D. B., Nafia, I., Melon, C., Shimamoto, K., Goff, L. K., & Had‐Aissouni, L. (2006) · Glia · doi:10.1002/glia.20353 · Cited by 26

3′ Untranslated Region in a Light Neurofilament (NF-L) mRNA Triggers Aggregation of NF-L and Mutant Superoxide Dismutase 1 Proteins in Neuronal Cells

Lin, H., Zhai, J., Cañete-Soler, R., & Schlaepfer, W. W. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.5689-03.2004 · Cited by 26

Multiple phases of expression and regulation of mouse Hoxc8 during early embryogenesis

Belting, H., Shashikant, C. S., & Ruddle, F. H. (1998) · Journal of Experimental Zoology · doi:10.1002/(sici)1097-010x(199809/10)282:1/2 · Cited by 46

Current therapy in amyotrophic lateral sclerosis (ALS): A review on past and future therapeutic strategies

Wei, Y., Zhong, S., Yang, H., Wang, X., Lv, B., Bian, Y., Pei, Y., Xu, C., Zhao, Q., Yulan, W., et al. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116496 · Cited by 28

Mitochondria in motor nerve terminals: function in health and in mutant superoxide dismutase 1 mouse models of familial ALS

Barrett, E. F., Barrett, J. N., & David, G. (2011) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-011-9392-1 · Cited by 25

Review: Microglia in motor neuron disease

Ashford, B., Boche, D., Cooper‐Knock, J., Heath, P. R., Simpson, J. E., & Highley, J. R. (2020) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12640 · Cited by 27

Decreased GLT‐1 and increased SOD1 and HO‐1 expression in astrocytes contribute to lumbar spinal cord vulnerability of SOD1‐G93A transgenic mice

Guo, Y., Duan, W., Li, Z., Huang, J., Yin, Y., Zhang, K., Wang, Q., Zhang, Z., & Li, C. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.03.025 · Cited by 25

Synchrotron-based infrared spectroscopy brings to light the structure of protein aggregates in neurodegenerative diseases

Hoffner, G., André, W., Sandt, C., & Djian, P. (2014) · Reviews in Analytical Chemistry · doi:10.1515/revac-2014-0016 · Cited by 25

Mitochondrial ROS and Apoptosis

El-Osta, H. E., & Circu, M. L. (2016) · Springer eBooks · doi:10.1007/978-3-319-42139-1_1 · Cited by 27

Stress-Dependent Changes in the CacyBP/SIP Interacting Protein S100A6 in the Mouse Brain

Bartkowska, K., Swiatek, I., Aniszewska, A., Jurewicz, E., Turlejski, K., Filipek, A., & Djavadian, R. L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169760 · Cited by 24

Astrocyte elevated gene-1 is a novel regulator of astrogliosis and excitatory amino acid transporter-2 via interplaying with nuclear factor-κB signaling in astrocytes from amyotrophic lateral sclerosis mouse model with hSOD1 G93A mutation

Yin, X. L., Wang, S., Qi, Y., Wang, X., Jiang, H., Wang, T., Yang, Y., Wang, Y., Zhang, C., & Feng, H. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.05.004 · Cited by 25

Amyotrophic lateral sclerosis: Protein chaperone dysfunction revealed by proteomic studies of animal models

Jain, M. R., Ge, W., Elkabes, S., & Hong Li, A. (2008) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200780023 · Cited by 25

Mechanism and treatment of motoneuron degeneration in ALS: What have SOD1 mutants told us?

Xu, Z. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820050515052 · Cited by 25

Sublethal enteroviral infection exacerbates disease progression in an ALS mouse model

Xue, Y. C., Liu, H., Mohamud, Y., Bahreyni, A., Zhang, J., Cashman, N. R., & Luo, H. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02380-7 · Cited by 24

A Chemical Chaperone‐Based Drug Candidate is Effective in a Mouse Model of Amyotrophic Lateral Sclerosis (ALS)

Getter, T., Zaks, I., Barhum, Y., Ben‐Zur, T., Böselt, S., Gregoire, S., Viskind, O., Shani, T., Gottlieb, H. E., Green, O., et al. (2015) · ChemMedChem · doi:10.1002/cmdc.201500045 · Cited by 24

Motor neurones in culture as a model to study ALS

Silani, V., Braga, M., Ciammola, A., Cardin, V., & Scarlato, G. (2000) · Journal of Neurology · doi:10.1007/s004150050554 · Cited by 24

Stem Cells in Amyotrophic Lateral Sclerosis: Motor Neuron Protection or Replacement?

Silani, V., Calzarossa, C., Cova, L., & Ticozzi, N. (2010) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152710791292666 · Cited by 24

Postnatal electrical and morphological abnormalities in lumbar motoneurons from transgenic mouse models of amyotrophic lateral sclerosis.

Amendola, J., Guéritaud, J. P., d’Incamps, B. L., Bories, C., Liabeuf, S., Allène, C., Pambo-Pambo, A. B., & Durand, J. (2007) · PubMed · Cited by 24

Overexpression of mutated Cu,Zn-SOD in neuroblastoma cells results in cytoskeletal change

Takamiya, R., Takahashi, M., Park, Y. S., Tawara, Y., Fujiwara, N., Miyamoto, Y., Gu, J., Suzuki, K., & Taniguchi, N. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00014.2004 · Cited by 24

Therapeutic targets for amyotrophic lateral sclerosis: current treatments and prospects for more effective therapies

Bruijn, L. I., & Cudkowicz, M. (2006) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.6.3.417 · Cited by 24

Familial amyotrophic lateral sclerosis with widespread vacuolation and hyaline inclusions

Sasaki, S., Ohsawa, Y., Yamane, K., Sakuma, H., Shibata, N., Nakano, R., Kikugawa, K., Mizutani, T., Tsuji, S., & Iwata, M. (1998) · Neurology · doi:10.1212/wnl.51.3.871 · Cited by 24

Aggregation modulating elements in mutant human superoxide dismutase 1

Karch, C. M. M., & Borchelt, D. (2010) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.07.027 · Cited by 23

Novel chemical inhibitor against SOD1 misfolding and aggregation protects neuron-loss and ameliorates disease symptoms in ALS mouse model

Woo, T., Yoon, M.-H., Kang, S., Park, S., Cho, J.-H., Hwang, Y. J., Ahn, J., Jang, H., Shin, Y.-J., Jung, E., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02862-z · Cited by 24

SOD-1 Variants in Amyotrophic Lateral Sclerosis: Systematic Re-Evaluation According to ACMG-AMP Guidelines

Ruffo, P., Perrone, B., & Conforti, F. L. (2022) · Genes · doi:10.3390/genes13030537 · Cited by 26

Sigma-1 receptor maintains ATAD3A as a monomer to inhibit mitochondrial fragmentation at the mitochondria-associated membrane in amyotrophic lateral sclerosis

Watanabe, S., Horiuchi, M., Murata, Y., Komine, O., Kawade, N., Sobue, A., & Yamanaka, K. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106031 · Cited by 23

Abnormalities of protein kinases in neurodegenerative diseases

Wagey, R. T. E., & Krieger, C. (1998) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-8845-5_4 · Cited by 23

Hyperexcitability, persistent Na+ conductances and neurodegeneration in amyotrophic lateral sclerosis

Kiernan, M. C. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.03.039 · Cited by 23

Human glial progenitor engraftment and gene expression is independent of the ALS environment

Haidet-Phillips, A. M., Doreswamy, A., Gross, S. K., Tang, X., Campanelli, J. T., & Maragakis, N. J. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.12.011 · Cited by 24

Assessing the role of immuno-proteasomes in a mouse model of familial ALS

Puttaparthi, K., Kaer, L. V., & Elliott, J. L. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.03.024 · Cited by 23

Reduction in hSOD1 copy number significantly impacts ALS phenotype presentation in G37R (line 29) mice: implications for the assessment of putative therapeutic agents

Zwiegers, P., Lee, G., & Shaw, C. A. (2014) · Journal of Negative Results in BioMedicine · doi:10.1186/1477-5751-13-14 · Cited by 23

Toward precision medicine in amyotrophic lateral sclerosis.

Zou, Z., Liu, C.-Y., Che, C., & Huang, H. (2016) · PubMed · doi:10.3978/j.issn.2305-5839.2016.01.16 · Cited by 24

Intracerebroventricular administration of Cystatin C ameliorates disease in SOD1‐linked amyotrophic lateral sclerosis mice

Watanabe, S., Komine, O., Endo, F., Wakasugi, K., & Yamanaka, K. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14285 · Cited by 23

Therapeutic developments in the treatment of amyotrophic lateral sclerosis

Jackson, M. T., Lladó, J., & Rothstein, J. D. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.10.1343 · Cited by 23

Mechanisms of compensatory plasticity for respiratory motor neuron death

Seven, Y. B., & Mitchell, G. S. (2019) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2019.01.001 · Cited by 22

Coactivation of GSK3β and IGF-1 Attenuates Amyotrophic Lateral Sclerosis Nerve Fiber Cytopathies in SOD1 Mutant Patient-Derived Motor Neurons

Ting, H.-C., Yang, H.-I., Harn, H., Chiu, I., Su, H., Li, X., Chen, M., Ho, T., Liu, C.-A., Tsai, Y.-J., et al. (2021) · Cells · doi:10.3390/cells10102773 · Cited by 22

Genetic architecture of motor neuron diseases

Chaudhary, R., Agarwal, V., Rehman, M., Kaushik, A. S., & Mishra, V. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.120099 · Cited by 24

Pharmacological and Pathological Relevance of S100 Proteins in Neurological Disorders

Goswami, D., Anuradha, U., Angati, A., Kumari, N., & Singh, R. K. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527322666221128160653 · Cited by 22

Distinct biochemical signatures characterize peripherin isoform expression in both traumatic neuronal injury and motor neuron disease

McLean, J. R., Liu, H., Miletic, D., Weng, Y. C., Rogaeva, E. A., Zinman, L. H., Križ, J., & Robertson, J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06846.x · Cited by 22

Immunology primer for neurosurgeons and neurologists part 2: Innate brain immunity

Blaylock, R. L. (2013) · Surgical Neurology International · doi:10.4103/2152-7806.118349 · Cited by 23

Substance P receptor activation induces downregulation of the AMPA receptor functionality in cortical neurons from a genetic model of Amyotrophic Lateral Sclerosis

Caioli, S., Curcio, L., Pieri, M., Antonini, A., Marolda, R., Severini, C., & Zona, C. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.06.008 · Cited by 24

UPS Activation in the Battle Against Aging and Aggregation-Related Diseases: An Extended Review

Papaevgeniou, N., & Chondrogianni, N. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3756-1_1 · Cited by 23

Multimodal Synchrotron Radiation Microscopy of Intact Astrocytes from the hSOD1 G93A Rat Model of Amyotrophic Lateral Sclerosis

Dučić, T., Stamenković, S., Lai, B. C. H., Anđjus, P. R., & Lučić, V. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b04273 · Cited by 22

Ubiquitin–Synaptobrevin Fusion Protein Causes Degeneration of Presynaptic Motor Terminals in Mice

Liu, Y., Li, H., Sugiura, Y., Han, W., Gallardo, G., Khvotchev, M. V., Zhang, Y., Kavalali, E. T., Südhof, T. C., & Lin, W. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.5288-14.2015 · Cited by 22

Differential effects of phytotherapic preparations in the hSOD1 Drosophila melanogaster model of ALS

Rose, F. D., Marotta, R., Talani, G., Catelani, T., Solari, P., Poddighe, S., Borghero, G., Marrosu, F., Sanna, E., Kasture, S. B., et al. (2017) · Scientific Reports · doi:10.1038/srep41059 · Cited by 22

HSPB1 mutations causing hereditary neuropathy in humans disrupt non-cell autonomous protection of motor neurons

Heilman, P. L., Song, S., Miranda, C. J., Meyer, K., Srivastava, A. K., Knapp, A., Wier, C. G., Kaspar, B. K., & Kolb, S. J. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.08.002 · Cited by 22

Transgenic ALS Mice Show Increased Vulnerability to the Mitochondrial Toxins MPTP and 3-Nitropropionic Acid

Andreassen, O. A., Ferrante, R. J., Klivènyi, P., Klein, A., Dedeoglu, A., Albers, D. S., Kowall, N. W., & Beal, M. F. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7627 · Cited by 22

Progress in the modeling of neurodegenerative diseases in transgenic mice

Duff, K., & Rao, M. V. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200108000-00003 · Cited by 22

Identification of two novel mutations in the Cu/Zn superoxide dismutase gene with familial amyotrophic lateral sclerosis: mass spectrometric and genomic analyses

Sato, T., Yamamoto, Y., Nakanishi, T., Fukada, K., Sugai, F., Zhou, Z., Okuno, T., Nagano, S., Hirata, S., Shimizu, A., et al. (2003) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2003.11.003 · Cited by 22

Presymptomatic biochemical changes in hindlimb muscle of G93A human Cu/Zn superoxide dismutase 1 transgenic mouse model of amyotrophic lateral sclerosis

Park, K. H. J., & Vincent, I. J. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.04.001 · Cited by 22

Low-frequency magnetic fields do not aggravate disease in mouse models of Alzheimer's disease and amyotrophic lateral sclerosis

Liebl, M. P., Windschmitt, J., Besemer, A. S., Schäfer, A.-K., Reber, H., Behl, C., & Clement, A. M. (2015) · Scientific Reports · doi:10.1038/srep08585 · Cited by 25

Neuron-Microglia Interactions in Motor Neuron Degeneration. The Inflammatory Hypothesis in Amyotrophic Lateral Sclerosis Revisited

Rodríguez, M. J., & Mahy, N. (2016) · Current Medicinal Chemistry · doi:10.2174/0929867324666161123091314 · Cited by 22

Neuronal VPS35 deletion induces spinal cord motor neuron degeneration and early post-natal lethality

Sargent, D., Cunningham, L. A., Dues, D. J., Ma, Y., Kordich, J. J., Mercado, G., Brundin, P., Cowell, R. M., & Moore, D. J. (2021) · Brain Communications · doi:10.1093/braincomms/fcab208 · Cited by 21

Emerging Roles for Aberrant Astrocytic Calcium Signals in Parkinson’s Disease

Bancroft, E. A., & Srinivasan, R. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2021.812212 · Cited by 22

Widespread CNS pathology in amyotrophic lateral sclerosis homozygous for the D90A SOD1 mutation

Forsberg, K., Graffmo, K. S., Stenvall, E., Tabikh, N., Marklund, S. L., Brännström, T., & Andersen, P. M. (2022) · Acta Neuropathologica · doi:10.1007/s00401-022-02519-z · Cited by 22

Why should we care about astrocytes in a motor neuron disease?

Dittlau, K. S., & Bosch, L. V. D. (2023) · Frontiers in Molecular Medicine · doi:10.3389/fmmed.2023.1047540 · Cited by 24

Endocytic pathways of pathogenic protein aggregates in neurodegenerative diseases

Hivare, P., Mujmer, K., Swarup, G., Gupta, S. K., & Bhatia, D. D. (2023) · Traffic · doi:10.1111/tra.12906 · Cited by 24

Role of Astrocytes in Neurodegenerative Diseases

George, E., González, J., Capani, F., & Morales, L. (2011) · InTech eBooks · doi:10.5772/31166 · Cited by 21

A simultaneous release of SOD1 with cytochrome c regulates mitochondria-dependent apoptosis

Li, Q., Sato, E. F., Zhu, X., & Inoue, M. (2008) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-9952-9 · Cited by 21

An examination of αB‐crystallin as a modifier of SOD1 aggregate pathology and toxicity in models of familial amyotrophic lateral sclerosis

Karch, C. M. M., & Borchelt, D. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06572.x · Cited by 21

Elevated mRNA-levels of distinct mitochondrial and plasma membrane Ca2+ transporters in individual hypoglossal motor neurons of endstage SOD1 transgenic mice

hling, T. M. ⁄., Duda, J., Weishaupt, J. H., Ludolph, A. C., & Liss, B. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00353 · Cited by 21

Localization of a mutant SOD1 protein in E40K-heterozygous dogs: Implications for non-cell-autonomous pathogenesis of degenerative myelopathy

Kobatake, Y., Sakai, H., Tsukui, T., Yamato, O., Kohyama, M., Sasaki, J., Kato, S., Urushitani, M., Maeda, S., & Kamishina, H. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.10.034 · Cited by 21

Longitudinal assessment of metal concentrations and copper isotope ratios in the G93A SOD1 mouse model of amyotrophic lateral sclerosis

Enge, T. G., Ecroyd, H. W., Jolley, D. F., Yerbury, J. J., & Dosseto, A. (2016) · Metallomics · doi:10.1039/c6mt00270f · Cited by 22

Amyotrophic lateral sclerosis-related mutant superoxide dismutase 1 aggregates inhibit 14-3-3-mediated cell survival by sequestration into the JUNQ compartment

Park, J.-H., Jang, H. R., Lee, I. Y., Oh, H. K., Choi, E., Rhim, H., & Kang, S. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx250 · Cited by 21

EAAT1 and EAAT2 immunoreactivity in transgenic mice with a G93A mutant SOD1 gene

Sasaki, S., Warita, H., Abe, K., Komori, T., & Iwata, M. (2001) · Neuroreport · doi:10.1097/00001756-200105250-00014 · Cited by 21

Impaired SDF1/CXCR4 signaling in glial progenitors derived from SOD1G93A mice

Luo, Y., Xue, H., Pardo, A. C., Mattson, M. P., Rao, M. S., & Maragakis, N. J. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21398 · Cited by 21

HoxB2 binds mutant SOD1 and is altered in transgenic model of ALS

Zhai, J., Lin, H., Cañete-Soler, R., & Schlaepfer, W. W. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi297 · Cited by 21

Abnormal response of distal Schwann cells to denervation in a mouse model of motor neuron disease

Carrasco, D. I., Bahr, B. A., Seburn, K. L., & Pinter, M. J. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.02.002 · Cited by 21

Late appearance of glutamate transporter defects in a murine model of ALS–parkinsonism dementia complex

WILSON, J., & SHAW, C. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.09.017 · Cited by 21

Prospects for the Pharmacotherapy of Amyotrophic Lateral Sclerosis

Festoff, B. W., Suo, Z., & Citron, B. A. (2003) · CNS Drugs · doi:10.2165/00023210-200317100-00002 · Cited by 21

Differential RNA cleavage and polyadenylation of the glutamate transporter EAAT2 in the human brain

Münch, C., Schwalenstöcker, B., Hermann, C., Cirovic, S., Stamm, S., Ludolph, A. C., & Meyer, T. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00139-x · Cited by 21

Extra Axonal Neurofilaments Do Not Exacerbate Disease Caused by Mutant Cu,Zn Superoxide Dismutase

Couillard‐Després, S., Meier, J., & Julien, J. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0296 · Cited by 21

Application of antisense oligonucleotide drugs in amyotrophic lateral sclerosis and Huntington’s disease

Ou, K., Jia, Q., Li, D., Li, S., Li, X., & Yin, P. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00466-9 · Cited by 23

Knockdown of GADD34 in neonatal mutant SOD1 mice ameliorates ALS

Ghadge, G. D., Sonobe, Y., Camarena, A., Drigotas, C., Rigo, F., Ling, K., & Roos, R. P. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104702 · Cited by 22

Proteostasis impairment and ALS

Lambert-Smith, I. A., Saunders, D. N., & Yerbury, J. J. (2022) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2022.06.001 · Cited by 19

Different Human Copper-Zinc Superoxide Dismutase Mutants, SOD1G93A and SOD1H46R, Exert Distinct Harmful Effects on Gross Phenotype in Mice

Pan, L., Yoshii, Y., Otomo, A., Ogawa, H. K., Iwasaki, Y., Shang, H., & Hadano, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033409 · Cited by 20

Role of the ubiquitin–proteasome system in nervous system function and disease: using C. elegans as a dissecting tool

Baptista, M. S., Duarte, C. B., & Maciel, P. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-0946-0 · Cited by 19

In Vivo NMR Studies of the Brain with Hereditary or Acquired Metabolic Disorders

Sherry, E. B., Lee, P., & Choi, I.-Y. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1772-1 · Cited by 22

Stressing Out Hsp90 in Neurotoxic Proteinopathies

Inda, C., Bolaender, A., Wang, T., Gandu, S. R., & Koren, J. (2016) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026616666160413141350 · Cited by 20

Exploring the cause of aggregation and reduced Zn binding affinity by G85R mutation in SOD1 rendering amyotrophic lateral sclerosis

Srinivasan, E., & Rajasekaran, R. (2017) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.25288 · Cited by 20

Astrocytes in Motor Neuron Diseases

Valori, C. F., Guidotti, G., Brambilla, L., & Rossi, D. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-9913-8_10 · Cited by 19

Imaging of glial cell morphology, SOD1 distribution and elemental composition in the brainstem and hippocampus of the ALS hSOD1G93A rat

Stamenković, S., Dučić, T., Stamenković, V., Kranz, A., & Anđjus, P. R. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.05.041 · Cited by 19

Creatine and coenzyme Q10 in the treatment of ALS

Strong, M. J., & Pattee, G. L. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/14660820050515665 · Cited by 20

The role of excitatory amino acid transporter 2 (EAAT2) in epilepsy and other neurological disorders

Alijanpour, S., Miryounesi, M., & Ghafouri‐Fard, S. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-01091-5 · Cited by 20

Neurogenetics II: complex disorders

Wright, A. F. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.047704 · Cited by 19

Effects of Tongue Force Training on Bulbar Motor Function in the Female SOD1-G93A Rat Model of Amyotrophic Lateral Sclerosis

Ma, D., Shuler, J. M., Kumar, A. P. R., Stanford, Q. R., Tungtur, S. K., Nishimune, H., & Stanford, J. A. (2016) · Neurorehabilitation and neural repair · doi:10.1177/1545968316666956 · Cited by 18

Modulation of histone H3K4 dimethylation by spermidine ameliorates motor neuron survival and neuropathology in a mouse model of ALS

Choi, S.-H., Yousefian-Jazi, A., Hyeon, S. J., Nguyen, P. T., Chu, J., Kim, S., Kim, S., Ryu, H. L., Kowall, N. W., Ryu, H., et al. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00890-3 · Cited by 18

Brain-derived neurotrophic factor/tropomyosin receptor kinase B signaling in spinal muscular atrophy and amyotrophic lateral sclerosis

Deng, C., & Chen, H. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106377 · Cited by 18

Progress in Therapy Development for Amyotrophic Lateral Sclerosis

Venkova-Hristova, K., Christov, A., Kamaluddin, Z., Kobalka, P. J., & Hensley, K. (2012) · Neurology Research International · doi:10.1155/2012/187234 · Cited by 18

Repetitive nerve stimulation transiently opens the mitochondrial permeability transition pore in motor nerve terminals of symptomatic mutant SOD1 mice

Nguyen, K. T. V., Barrett, J. N., Garcia-Chacon, L. E., David, G., & Barrett, E. F. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.01.031 · Cited by 19

Mahogunin ring finger 1 confers cytoprotection against mutant SOD1 aggresomes and is defective in an ALS mouse model

Chhangani, D., Endo, F., Amanullah, A., Upadhyay, A., Watanabe, S., Mishra, R., Yamanaka, K., & Mishra, A. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.11.017 · Cited by 18

Antagonizing bone morphogenetic protein 4 attenuates disease progression in a rat model of amyotrophic lateral sclerosis

Shijo, T., Warita, H., Suzuki, N., Ikeda, K., Mitsuzawa, S., Akiyama, T., Ono, H., Nishiyama, A., Izumi, R., Kitajima, Y., et al. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.06.009 · Cited by 18

Moving toward a predictive and personalized clinical approach in amyotrophic lateral sclerosis: novel developments and future directions in diagnosis, genetics, pathogenesis and therapies

Nefussy, B., & Drory, V. E. (2010) · The EPMA Journal · doi:10.1007/s13167-010-0027-0 · Cited by 18

ALS-linked SOD1 in glial cells enhances ß-N-Methylamino L-Alanine (BMAA)-induced toxicity in Drosophila

Islam, R., Kumimoto, E. L., Bao, H., & Zhang, B. (2012) · F1000Research · doi:10.12688/f1000research.1-47.v1 · Cited by 18

Neuronal tissue-specific ribonucleoprotein complex formation on SOD1 mRNA: Alterations by ALS SOD1 mutations

Ge, W., Leystra‐Lantz, C., Sanelli, T. R., McLean, J. R., Wen, W., Strong, W., & Strong, M. J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.03.007 · Cited by 18

Direct and indirect mechanisms for wild-type SOD1 to enhance the toxicity of mutant SOD1 in bigenic transgenic mice

Xu, G. M., Ayers, J. I., Roberts, B. L., Brown, H. H., Fromholt, S., Green, C., & Borchelt, D. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu517 · Cited by 18

Functional and Morphological Assessment of Diaphragm Innervation by Phrenic Motor Neurons

Martin, M., Li, K., Wright, M. C., & Lepore, A. C. (2015) · Journal of Visualized Experiments · doi:10.3791/52605 · Cited by 18

Early Detection of Motor Dysfunction in the SOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis (ALS) Using Home Cage Running Wheels

Bennett, E., Mead, R. J., Azzouz, M., Shaw, P. J., & Grierson, A. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107918 · Cited by 18

Slow component of axonal transport is impaired in the proximal axon of transgenic mice with a G93A mutant SOD1 gene

Sasaki, S., Warita, H., Abe, K., & Iwata, M. (2004) · Acta Neuropathologica · doi:10.1007/s00401-004-0838-y · Cited by 18

Astroglial alterations in amyotrophic lateral sclerosis (ALS) model of slow glutamate excitotoxicity in vitro.

Matyja, E., Taraszewska, A., Nagańska, E., Rafałowska, J., & Gębarowska, J. (2006) · PubMed · Cited by 18

Astrocyte loss of mutant SOD1 delays ALS disease onset and progression in G85R transgenic mice

Wang, L., Gutmann, D. H., & Roos, R. P. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq463 · Cited by 214

SOD1 Mutations Causing Familial Amyotrophic Lateral Sclerosis Induce Toxicity in Astrocytes: Evidence for Bystander Effects in a Continuum of Astrogliosis

Wallis, N., Lau, C. L., Farg, M. A., Atkin, J. D., Beart, P. M., & O’Shea, R. D. (2017) · Neurochemical Research · doi:10.1007/s11064-017-2385-7 · Cited by 14

Issue Cover (October 2015)

(2015) · Journal of Neurochemistry · doi:10.1111/jnc.12905

Restricted Expression of G86R Cu/Zn Superoxide Dismutase in Astrocytes Results in Astrocytosis But Does Not Cause Motoneuron Degeneration

Gong, Y. H., Parsadanian, A. S., Andreeva, A., Snider, W. D., & Elliott, J. L. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-02-00660.2000 · Cited by 387

Astrocytes from familial and sporadic ALS patients are toxic to motor neurons

Swami, M. (2011) · Nature Medicine · doi:10.1038/nm.2484 · Cited by 33